4,472 Shares in Astera Labs, Inc. $ALAB Purchased by Edgestream Partners L.P.

Edgestream Partners L.P. purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 4,472 shares of the company’s stock, valued at approximately $1,592,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. SBI Okasan Asset Management Co.Ltd. increased its holdings in shares of Astera Labs by 873.1% in the third quarter. SBI Okasan Asset Management Co.Ltd. now owns 1,664 shares of the company’s stock worth $595,000 after acquiring an additional 1,493 shares in the last quarter. Harbour Investments Inc. lifted its holdings in shares of Astera Labs by 15.9% during the 3rd quarter. Harbour Investments Inc. now owns 3,231 shares of the company’s stock valued at $1,150,000 after purchasing an additional 444 shares in the last quarter. AlTi Global Inc. lifted its holdings in shares of Astera Labs by 1.1% during the 3rd quarter. AlTi Global Inc. now owns 5,977 shares of the company’s stock valued at $2,128,000 after purchasing an additional 67 shares in the last quarter. Danica Pension Livsforsikringsaktieselskab acquired a new position in shares of Astera Labs in the 3rd quarter valued at approximately $794,000. Finally, Danske Bank A S increased its stake in Astera Labs by 9.4% during the 3rd quarter. Danske Bank A S now owns 75,605 shares of the company’s stock worth $26,913,000 after purchasing an additional 6,505 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Price Performance

Astera Labs stock opened at $179.58 on Friday. The firm has a market capitalization of $31.39 billion, a PE ratio of 71.55 and a beta of 3.85. The company’s 50-day moving average is $285.19 and its 200-day moving average is $258.24. Astera Labs, Inc. has a fifty-two week low of $97.89 and a fifty-two week high of $499.48.

Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.19 by $0.13. The business had revenue of $584.90 million for the quarter, compared to analyst estimates of $550.78 million. Astera Labs had a return on equity of 25.35% and a net margin of 29.64%. The firm’s revenue was up 153.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.49 EPS. As a group, analysts expect that Astera Labs, Inc. will post 2.99 EPS for the current year.

Wall Street Analysts Forecast Growth

ALAB has been the subject of several research reports. TD Cowen lowered their price objective on shares of Astera Labs from $300.00 to $225.00 and set a “hold” rating for the company in a research report on Wednesday, November 4th. Citigroup lowered shares of Astera Labs from a “buy” rating to a “hold” rating in a research note on Friday, October 9th. Roth Capital reiterated a “buy” rating and set a $450.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. UBS Group lowered their target price on Astera Labs from $300.00 to $290.00 and set a “neutral” rating for the company in a report on Wednesday, November 4th. Finally, Northland Securities raised Astera Labs from a “market perform” rating to an “outperform” rating and set a $315.00 price target on the stock in a research note on Wednesday, November 4th. Twelve analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and a consensus target price of $325.89.

Get Our Latest Stock Report on ALAB

Insider Buying and Selling

In related news, General Counsel Philip Mazzara sold 4,380 shares of the company’s stock in a transaction dated Monday, November 16th. The shares were sold at an average price of $206.62, for a total value of $904,995.60. Following the transaction, the general counsel directly owned 92,190 shares in the company, valued at approximately $19,048,297.80. This represents a 4.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Jitendra Mohan sold 96,089 shares of the stock in a transaction that occurred on Monday, November 16th. The stock was sold at an average price of $206.62, for a total transaction of $19,853,909.18. Following the transaction, the chief executive officer owned 1,170,576 shares in the company, valued at approximately $241,864,413.12. The trade was a 7.59% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 417,090 shares of company stock valued at $102,663,347 in the last 90 days. 10.40% of the stock is currently owned by corporate insiders.

Astera Labs Company Profile

(Free Report)

Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Featured Stories

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.